ArticleEJNMMI radiopharmacy and chemistry2017
DATATOC: a novel conjugate for kit-type
Article in EJNMMI radiopharmacy and chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Fibroblast activation protein targeting radiopharmaceuticals: From drug design to clinical translation.Acta pharmaceutica Sinica. B · 2025Review
- First-in-human study of an optimized, potential kit-type, SSTR antagonistTheranostics · 2025Article
- The effects of novel macrocyclic chelates on the targeting properties of theEJNMMI research · 2023Article
- [Pharmaceutics · 2023Article
- Modern Developments in Bifunctional Chelator Design for Gallium Radiopharmaceuticals.Molecules (Basel, Switzerland) · 2022Review
- [International journal of molecular sciences · 2022Article
- Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets.Pharmaceuticals (Basel, Switzerland) · 2022Article
- AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications.Pharmaceuticals (Basel, Switzerland) · 2022Review
- Cold Kit Labeling: The Future ofFrontiers in medicine · 2022Review
- Article
- Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATAEJNMMI radiopharmacy and chemistry · 2020Article
- Evaluation of [European journal of nuclear medicine and molecular imaging · 2020Article
- AAZTAEJNMMI radiopharmacy and chemistry · 2019Article
- Instant kit preparation ofEJNMMI research · 2019Article
- Article
- Erratum: Publisher Correction toEJNMMI radiopharmacy and chemistry · 2018Article
- Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2018Article
- Article
- New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.Molecules (Basel, Switzerland) · 2017Review
- Insulinoma - The incremental value of somatostatin receptor positron emission tomography.Indian journal of endocrinology and metabolismArticle
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe widespread acceptance and application of
resultsA BFC derived from the DATA ligand (2,2'-(6-((carboxymethyl)amino)-1,4-diazepane-1,4-diyl)diacetic acid) has been synthesised in five steps from simple building blocks, with an overall yield of 8 %. DATA
conclusionsThe favourable labelling properties of the DATA chelators have been retained for DATATOC. High radiochemical purity can be achieved at 23 °C in less than 1 min and from a kit formulation. The speed, reliability, ease, flexibility and simplicity with which
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.